神開股份(002278.SZ):已完成回購 累計回購2.75%的股份
格隆匯3月1日丨神開股份(002278.SZ)公佈,截至2022年3月1日,公司通過股份回購專用證券賬户以集中競價交易方式累計回購公司股份1000萬股,佔公司總股本的2.75%,最高成交價為6.78元/股,最低成交價為5.77元/股,成交總金額為6252.76萬元(含交易費用)。
公司實施股份回購的資金總額、回購價格、回購股份數量、回購實施期限等,符合公司第四屆董事會第四次會議審議通過的回購方案。回購股數已達到回購方案中的回購數量下限,且未超過回購數量上限,回購金額亦未超過回購總金額的上限,已按回購方案完成回購。公司回購實際執行情況與披露的回購方案不存在差異。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.